Elizabeth C. Richards

Statistics

Publications

Citations

1.2K

H-Index

Active since

1994

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Ludwig Cancer Research

Elizabeth C. Richards is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, pharmacokinetics of monoclonal antibodies, and immunology.

Publications per year

1994–2022

Publications

Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer.

S Welt, Andrew M. Scott, C R Divgi et al. · Journal of Clinical Oncology · 1996 · 226 citations

Medicine, Nuclear Medicine, Pharmacology +17

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma.

Yuji Noguchi, Elizabeth C. Richards, Yu Chen et al. · Proceedings of the National Academy of Sciences · 1995 · 214 citations

Life Sciences, Immunology, Oncology +17

TNF-α-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection

José Trevejo, Michael W. Marino, Nicola Philpott et al. · Proceedings of the National Academy of Sciences · 2001 · 198 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33.

Genrikh S. Ritter, Lawrence Cohen, C.M. Williams et al. · PubMed · 2001 · 143 citations

Pharmacy, Immunology, Oncology +17

Effect of interleukin 12 on tumor induction by 3-methylcholanthrene.

Yuji Noguchi, A. Jungbluth, Elizabeth C. Richards et al. · Proceedings of the National Academy of Sciences · 1996 · 142 citations

Medicine, Oncology, Pharmacology +14

1–5 of 9